Investors rush to join €750m fundraise for AXA life-sciences real estate fund
Oversubscribed AXA European Life Science Strategy to expand Kadans platform acquired last year
You have now reached your article limit
Already a registered user or subscriber? Sign in here
To continue reading, register free today for access
Registration also includes access to IPE
Five reasons to register today
- Access IPE Real Assets articles
- Daily news alerts and updates
- Track what the world’s leading institutional investors are doing
- Learn about the latest industry research and market analysis
- Comprehensive archive of data and intelligence on investors and fund managers
Copyright © 1997–2024 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP